Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
05/2005
05/19/2005US20050107577 Reacting monoalkoxyamines and polyfunctional compounds; used as radical polymerization initiators for the synthesis of polyfunctional living copolymers; thermal stability
05/19/2005US20050107447 phosphatase resistance; for enhancing wound repair; for treating reperfusion injuries/preventing tissue damage
05/19/2005US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists
05/19/2005US20050107343 Pyrrolo[2,3-d]pyrimidin-2-ylamines substituted in the 7th position by a aryl, heteroaryl, alicyclic, or heterocyclic group connected by methyl, C(O) , C(S) , S(O) or SO2; used in the treatment and prevention of various Heat Shock Protein 90 mediated disorders, e.g., proliferative disorders
05/19/2005US20050107341 Enzyme inhibitor of beta -secretase, for the treatment of Alzheimer's disease; {(R)-1-[3-(methyl-propyl-carbamoyl)-benzoylamino]-2-phenyl-ethyl}-(2-phenylcarbamoyl-propyl)-phosphinic acid; chemical intermediates
05/19/2005US20050107340 Protein kinase modulators; cancer, diabetes, hepatic cirrhosis, cardiovascular disease such as atherosclerosis, angiogenesis, immunological disease such as autoimmune disease (e.g., AIDS and lupus) and renal disease
05/19/2005US20050107339 Diphenylethylene compounds and uses thereof
05/19/2005US20050107337 Platinum complexes having antitumor activity
05/19/2005US20050107248 Metallic catalysts for chemo-, regio-and stereoselective reactions, and corresponding precursors
05/19/2005US20050106109 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes
05/19/2005US20050104031 Water treatment; reaction product of amine and phosphoric acid, phosphonic acid; treat water in a boiler and boiler feedlines or cooling tower; water purification
05/19/2005DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/19/2005DE10345572A1 Metallkomplexe Metal complexes
05/19/2005CA2544203A1 Phosphinic acids derivatives, beta-secretase inhibitors for the treatment of alzheimer's disease
05/19/2005CA2543880A1 Diastereoselective method of preparing olefins by means of the horner-wadsworth-emmons reaction using a particular phosphonate which improves diastereoselectivity at all temperatures including at ambient temperature
05/18/2005EP1531157A1 Cardioprotective phosphonates
05/18/2005EP1531155A1 Asymmetrical linear organic oligomers
05/18/2005EP1530609A1 Antistatic and antidust agents, compositions thereof, and methods of manufacture
05/18/2005EP1530577A1 Organophosphorous compounds having polysulfide bridge
05/18/2005EP1274738B1 Polymerizable compounds and uses thereof
05/18/2005EP0820461B1 Aryl-ester phosphoramidate derivatives of 2',3'-didehydronucleosides
05/18/2005CN1617900A Polymeric, phosphorous-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions
05/18/2005CN1617892A Supported bis(phosphorus) ligands and their use in the catalysis
05/18/2005CN1617876A Method for producing diphosphine compound and intermediate for producing the same
05/18/2005CN1617868A Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
05/18/2005CN1617764A Phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions
05/18/2005CN1616470A Chiral monophosphorous ligand, synthetic method and its use
05/18/2005CN1616469A Method for coproducing acetyl chloride and hydroxy ethylidene diphosphonic acid
05/18/2005CN1616111A Diagnostic imaging contrast agents with extended blood retention
05/18/2005CN1202141C High metathesis activity rethenium and osmium metal carbene complexes
05/17/2005US6894197 Process for producing fluorinated alcohol
05/17/2005US6894175 Drugs, cosmetics
05/17/2005US6893996 Process for the preparation of a nickel/phosphorous ligand catalyst for olefin hydrocyanation
05/17/2005US6893774 For use in electrolytes, primary batteries, secondary batteries, capacitors, supercapacitors or galvanic cells
05/17/2005US6893626 Compositions for TRP-M8 binding and radioreceptor methods therewith
05/17/2005US6893564 Shaped bodies containing metal-organic frameworks
05/17/2005CA2136597C Hydrazine derivatives and uses thereof
05/12/2005WO2005042562A2 New coupling agents for peptide synthesis
05/12/2005WO2005042550A1 Metal complexes with bipodal ligands
05/12/2005WO2005042547A1 Sterically hindered chelate phosphinite-phosphite ligand, catalyst, comprising at least one nickel(0) complex stabilized by said ligand and method for production of nitriles
05/12/2005WO2005042546A2 Diazaphosphacycles
05/12/2005WO2005042488A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
05/12/2005WO2005042471A1 Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
05/12/2005WO2005041899A2 Orally available sphingosine 1-phosphate receptor agonists and antagonists
05/12/2005WO2005007635A8 Combretastatin derivatives with cytotoxic action
05/12/2005WO2004087061B1 Tubulin binding agents and corresponding prodrug constructs
05/12/2005WO2003006454A8 Heterocyclic carboxamides and their use as fungicides
05/12/2005WO2002072591A8 Resveratrol-phospholipids complexes
05/12/2005US20050101802 Engines with seals and lubricants in noncatalytic reactions and packages
05/12/2005US20050101793 Method for preparing a biphenylphosphonate compound
05/12/2005US20050101781 Eponemycin and epoxomicin analogs and uses thereof
05/12/2005US20050101775 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging
05/12/2005US20050100976 Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
05/12/2005US20050100511 Photoactive layer containing a lanthanide complex selected from [Ln( beta -enolate)3(phosphine oxide-pyridine N-oxide) derivatives
05/12/2005CA2544335A1 Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents
05/12/2005CA2543930A1 New coupling agents for peptide synthesis
05/12/2005CA2543673A1 Sterically hindered chelate phosphinite-phosphite ligand, catalyst, comprising at least one nickel(0) complex stabilized by said ligand and method for production of nitriles
05/12/2005CA2543529A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
05/12/2005CA2542539A1 Diimine ligand, metal compound, olefin polymerization process
05/12/2005CA2487210A1 Asymmetrical linear organic oligomers
05/11/2005EP1529829A1 Process for producing zinc dialkyldithiophosphates exhibiting improved seal compatibility properties
05/11/2005EP1529783A2 Derivatives of 9,10-dihydro-9-oxa-10-phosphaphenanthren-10-oxide
05/11/2005EP1529090A1 Compounds comprising phosphorus-containing metal complexes
05/11/2005EP1529073A1 Blocked mercaptosilane hydrolyzates as coupling agents for mineral-filled elastomer compositions
05/11/2005EP1528957A2 Collecting agent for sulphidic ores
05/11/2005EP1230549B1 Method for solubilising optical markers
05/11/2005CN1200944C Method for producing N-phosphonomethyl iminodiacetic acid
05/11/2005CN1200943C Organometallic acyl-aryl phosphine
05/11/2005CN1200942C Stabilization process of phosphate esters using benzofuranone
05/11/2005CN1200713C New (aminopropyl) methylphosphinic acids
05/10/2005US6891057 Compounds for generating chemiluminescence with a peroxidase
05/10/2005US6890922 For treatment of erectile dysfunction as well as female sexual dysfunction, incontinence, and hypertrophy of the prostate; inhibitors of cGMP-metabolizing phosphodiesterases (cGMP= cyclic guanosine monophosphate)
05/10/2005CA2278290C Quinazolinone compounds
05/06/2005WO2005040357A2 Compounds and methods for fluorescent labeling
05/06/2005WO2005040178A1 Transition metal complex ligand and olefin polymerization catalyst containing transition metal complex
05/06/2005WO2005040177A1 Process to prepare alkyl phenyl phosphates
05/06/2005WO2005040176A2 Methods for the preparation of {2-[8,9-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl}phosphonic acid and esters thereof
05/06/2005WO2005039552A2 Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives
05/06/2005WO2005039504A2 Compounds and methods for treating toll-like receptor 2-related diseases and conditions
05/06/2005WO2005014604A3 Method for the production of cyclic phosphonic acid anhydrides
05/06/2005WO2005014604A2 Method for the production of cyclic phosphonic acid anhydrides
05/06/2005WO2005012324A3 Nucleobase phosphonate analogs for antiviral treatment
05/06/2005WO2005002626A8 Therapeutic phosphonate compounds
05/06/2005WO2004096287A3 Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
05/06/2005WO2004090154A3 Acyl- phosphate and phosphonate probes and methods of their synthesis and use in proteomic analysis
05/06/2005WO2004067505A3 Bismuth dithiocarbamate compounds and uses thereof
05/06/2005CA2543008A1 Methods for the preparation of {2-[8,9-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl}phosphonic acid and esters thereof
05/06/2005CA2542967A1 Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives
05/05/2005US20050096470 novel intermediate (5-substituted) (6-substituted) 6H-imidazo[4,5-c]tetrazolo[1,5-a]quinoline compounds of given formula; intermediate to antiviral immunomodulator 1H-imidazo[4,5-c]quinolin-4-amines
05/05/2005US20050096465 Reacting an aldehyde or acetal having at least one phosphono group ubstituted thereon with pyrrole to produce a phosphono-substituted dipyrromethane
05/05/2005US20050096385 reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity
05/05/2005US20050096298 Purine compounds for treatment of bone disorders or cancer
05/05/2005US20050095204 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes
05/05/2005US20050095203 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes
05/05/2005US20050095202 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes
05/04/2005EP1528065A1 Process for the preparation of an alkenyl phosphonic acid derivative
05/04/2005EP1528064A1 Process for the preparation of an alkenyl phosphonic acid derivative
05/04/2005EP1528063A1 Compound having phosphorylcholine group, polymer thereof, and process for producing the same
05/04/2005EP1527079A2 Alkoxyamines originating from beta-phosphorylated nitroxides and use thereof in radical polymerisation
05/04/2005EP1527078A2 Novel phosphonocarboxylic acid esters
1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 554